Frontlight ResearchEarly access
WithdrawnNo phase
Clinical Validation of Suntech Advantage MX With Suntech Neonate and Children Cuff Line
Key facts
- Who runs it
- SunTech Medical
- Where
- Los Angeles, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 7 Nov 2023
- Ended
- 1 Mar 2024
- Type of study
- Observational, 5 groups
- Treatments tested
- Advantage MX Module
- Record updated
- 5 March 2024
- Why it stopped
- no enrollment
Who can take part
- Age
- 1 month to 3 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- At least 3 subjects shall be < 1,000g in weight
- At least 3 subjects shall be 1,000g to 2,000g in weight
- At least 3 subjects shall be >2,000g
- At least 3 subjects shall be ≥ 29 days and < 1 year of age
- At least 3 subjects shall be ≥ 1 year and < 3 years of age
Who cannot take part
- Patients who are prescribed anti-coagulation medication during the enrollment process or begin anti-coagulation medication after enrollment are ineligible to participate in the study
- Patients found to have a-fib, irregular heart rhythm, dysrhythmias, bigeminy, trigeminy, and isolated premature ventricular beats (VPBs) during the enrollment process are to be ineligibile to participate in the study
- Subjects who study personnel determine invasive blood pressure measurements will be unreliable
- Exclusions can also occur post-data review based on exclusion criteria according to ANSI/AAMI/ISO 81060-2:2019
Where in United States
- Children's Hospital of Los AngelesLos Angeles, United States
About the trial
What the trial wants to find out
Patients will be selected according to specific criteria. Upon selection, patients with an existing intra-arterial line will have their blood pressure monitored with the SunTech Advantage MX module in addition to the reference data collected from intra-arterial line. Data collected from the Advantage MX module will be compared to the reference data from the intra-arterial line.
The 5 groups in the trial
- At least 3 subjects shall be <1,000g in weight
Treatment: Advantage MX Module
- At least 3 subjects shall be 1,000g to 2,000g in weight
Treatment: Advantage MX Module
- At least 3 subjects shall be >2,000g
Treatment: Advantage MX Module
- At least 3 subjects shall be >/= 29 days and < 1 year of age
Treatment: Advantage MX Module
- At least 3 subjects shall be >/= 1 year and <3 years of age
Treatment: Advantage MX Module
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical Validation of Suntech Advantage MX With Suntech Neonate and Children Cuff Line Against Invasive Intra-arterial Reference According to the ANSI/AAMI/ISO 810602-2019 Protocol for Neonates, Infants, Children
- Record updated
- 5 March 2024